Retractable Technologies (RVP) Non Operating Interest Expenses (2010 - 2026)
Retractable Technologies' (RVP) quarterly Non Operating Interest Expenses came in at $18705.0 in Q2 2026, down 15.96% on a YoY basis from $22257.0 in Q2 2025, and down 8.49% quarter-over-quarter from $20441.0 in Q1 2026.
Analysis
Retractable Technologies (RVP) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends
Retractable Technologies (RVP) has reported Non Operating Interest Expenses for 17 consecutive years, with $18705.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non Operating Interest Expenses fell 15.96% year-over-year to $18705.0; the trailing twelve-month figure through Jun 2026 stood at $81340.0 (down 20.96% YoY), and the FY2025 full-year result was $87904.0, down 28.24% from the prior year.
- Non Operating Interest Expenses eased to $18705.0 in Q2 2026 per RVP's latest filing, from $20441.0 in the prior quarter.
- Across five years, Non Operating Interest Expenses topped out at $47105.0 in Q1 2022 and bottomed at $18705.0 in Q2 2026.
- Historically, Non Operating Interest Expenses has averaged $31798.3 across 5 years, with a median of $32650.0 in 2024.
- The sharpest annual moves came in 2023 and 2025: Non Operating Interest Expenses slipped 2.34% in 2023, then plunged 32.48% in 2025.
- Over 5 years, Non Operating Interest Expenses stood at $44905.0 in 2022, then retreated by 21.93% to $35056.0 in 2023, then declined by 23.8% to $26711.0 in 2024, then slipped by 19.1% to $21609.0 in 2025, then retreated by 13.44% to $18705.0 in 2026.
- According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $18705.0, $20441.0, and $21609.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 50.32 Bn | 49.46 Bn | 2.32 Bn | 132.00 Mn |
| 2 | Medline | 48.11 Bn | 52.93 Bn | 2.22 Bn | - |
| 3 | West Pharmaceutical Services | 23.93 Bn | 23.49 Bn | 329.20 Mn | 2.60 Mn |
| 4 | Baxter International | 13.34 Bn | 11.16 Bn | 1.03 Bn | - |
| 5 | Stevanato Group S.p.A | 6.21 Bn | 6.11 Bn | 100.91 Mn | 2.31 Mn |
| 6 | Acme United | 241.34 Mn | 236.30 Mn | 26.69 Mn | - |
| 7 | Rockwell Medical | 31.74 Mn | 6.94 Mn | 3.24 Mn | 281,000.00 |
| 8 | Retractable Technologies | 21.26 Mn | -18.61 Mn | 190,852.00 | 18,705.00 |
| 9 | United Health Products | 12.24 Mn | 12.21 Mn | - | 50,456.00 |
| 10 | Cuprina Holdings (Cayman) | 8.09 Mn | 4.97 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18,705.00 |
| Mar 31, 2026 | 20,441.00 |
| Dec 31, 2025 | 21,609.00 |
| Sep 30, 2025 | 20,585.00 |
| Jun 30, 2025 | 22,257.00 |
| Mar 31, 2025 | 23,455.00 |
| Dec 31, 2024 | 26,711.00 |
| Sep 30, 2024 | 30,489.00 |
| Jun 30, 2024 | 31,817.00 |
| Mar 31, 2024 | 33,483.00 |
| Dec 31, 2023 | 35,056.00 |
| Sep 30, 2023 | 36,087.00 |
| Jun 30, 2023 | 37,469.00 |
| Mar 31, 2023 | 43,555.00 |
| Dec 31, 2022 | 44,905.00 |
| Sep 30, 2022 | 40,273.00 |
| Jun 30, 2022 | 38,368.00 |
| Mar 31, 2022 | 47,105.00 |
| Dec 31, 2021 | 54,515.00 |
| Sep 30, 2021 | 52,886.00 |